Zdrowie i gospodarka · 30/04/2026
FDA Clears Fenofibrate Tablets for Sale
The FDA has determined that fenofibrate tablets, 40mg and 120mg, were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications.